Abstract
Neurofibromatosis 2 (NF2) patients with constitutional splice site NF2 mutations have greater variability in disease severity than NF2 patients with other types of mutations; the cause of this variability is unknown. We evaluated genotype-phenotype correlations, with particular focus on the location of splice site mutations, using mutation and clinical information on 831 patients from 528 NF2 families with identified constitutional NF2 mutations. The clinical characteristics examined were age at onset of symptoms of NF2 and number of intracranial meningiomas, which are the primary indices of the severity of NF2. Two regression models were used to analyse genotype-phenotype correlations. People with splice site mutations in exons 1–5 had more severe disease than those with splice site mutations in exons 11–15. This result is compatible with studies showing that exons 2 and 3 are required for self-association of the amino terminal of the NF2 protein in vitro, and that deletions of exons 2 and 3 in transgenic and knockout mouse models of NF2 cause a high prevalence of Schwann cell derived tumours.
Full Text
The Full Text of this article is available as a PDF (99.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baser M. E., Friedman J. M., Wallace A. J., Ramsden R. T., Joe H., Evans D. G. R. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology. 2002 Dec 10;59(11):1759–1765. doi: 10.1212/01.wnl.0000035638.74084.f4. [DOI] [PubMed] [Google Scholar]
- Baser M. E., Kuramoto L., Joe H., Friedman J. M., Wallace A. J., Ramsden R. T., Evans D. G. R. Genotype-phenotype correlations for cataracts in neurofibromatosis 2. J Med Genet. 2003 Oct;40(10):758–760. doi: 10.1136/jmg.40.10.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baser M. E., Ragge N. K., Riccardi V. M., Janus T., Gantz B., Pulst S. M. Phenotypic variability in monozygotic twins with neurofibromatosis 2. Am J Med Genet. 1996 Sep 6;64(4):563–567. doi: 10.1002/(SICI)1096-8628(19960906)64:4<563::AID-AJMG7>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
- Baser Michael E., Friedman J. M., Aeschliman Dana, Joe Harry, Wallace Andrew J., Ramsden Richard T., Evans D. Gareth R. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet. 2002 Aug 22;71(4):715–723. doi: 10.1086/342716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baser Michael E., Kuramoto Lisa, Joe Harry, Friedman J. M., Wallace Andrew J., Gillespie James E., Ramsden Richard T., Evans D. Gareth R. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. Am J Hum Genet. 2004 Jun 9;75(2):231–239. doi: 10.1086/422700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baser Michael E., Makariou Erini V., Parry Dilys M. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2. J Neurosurg. 2002 Feb;96(2):217–222. doi: 10.3171/jns.2002.96.2.0217. [DOI] [PubMed] [Google Scholar]
- Bruder C. E., Hirvelä C., Tapia-Paez I., Fransson I., Segraves R., Hamilton G., Zhang X. X., Evans D. G., Wallace A. J., Baser M. E. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet. 2001 Feb 1;10(3):271–282. doi: 10.1093/hmg/10.3.271. [DOI] [PubMed] [Google Scholar]
- Bruder C. E., Ichimura K., Blennow E., Ikeuchi T., Yamaguchi T., Yuasa Y., Collins V. P., Dumanski J. P. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene? Genes Chromosomes Cancer. 1999 Jun;25(2):184–190. [PubMed] [Google Scholar]
- Caspari R., Friedl W., Mandl M., Möslein G., Kadmon M., Knapp M., Jacobasch K. H., Ecker K. W., Kreissler-Haag D., Timmermanns G. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet. 1994 Mar 12;343(8898):629–632. doi: 10.1016/s0140-6736(94)92634-4. [DOI] [PubMed] [Google Scholar]
- Caspari R., Olschwang S., Friedl W., Mandl M., Boisson C., Böker T., Augustin A., Kadmon M., Möslein G., Thomas G. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet. 1995 Mar;4(3):337–340. doi: 10.1093/hmg/4.3.337. [DOI] [PubMed] [Google Scholar]
- Davies D. R., Armstrong J. G., Thakker N., Horner K., Guy S. P., Clancy T., Sloan P., Blair V., Dodd C., Warnes T. W. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet. 1995 Nov;57(5):1151–1158. [PMC free article] [PubMed] [Google Scholar]
- Den Bakker M. A., van Tilborg A. A., Kros J. M., Zwarthoff E. C. Truncated NF2 proteins are not detected in meningiomas and schwannomas. Neuropathology. 2001 Sep;21(3):168–173. doi: 10.1046/j.1440-1789.2001.00394.x. [DOI] [PubMed] [Google Scholar]
- Evans D. G., Huson S. M., Donnai D., Neary W., Blair V., Newton V., Harris R. A clinical study of type 2 neurofibromatosis. Q J Med. 1992 Aug;84(304):603–618. [PubMed] [Google Scholar]
- Evans D. G., Huson S. M., Donnai D., Neary W., Blair V., Teare D., Newton V., Strachan T., Ramsden R., Harris R. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet. 1992 Dec;29(12):841–846. doi: 10.1136/jmg.29.12.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans D. G., Trueman L., Wallace A., Collins S., Strachan T. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet. 1998 Jun;35(6):450–455. doi: 10.1136/jmg.35.6.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans D. G., Wallace A. J., Wu C. L., Trueman L., Ramsden R. T., Strachan T. Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis. Am J Hum Genet. 1998 Sep;63(3):727–736. doi: 10.1086/512074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giovannini M., Robanus-Maandag E., Niwa-Kawakita M., van der Valk M., Woodruff J. M., Goutebroze L., Mérel P., Berns A., Thomas G. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev. 1999 Apr 15;13(8):978–986. doi: 10.1101/gad.13.8.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giovannini M., Robanus-Maandag E., van der Valk M., Niwa-Kawakita M., Abramowski V., Goutebroze L., Woodruff J. M., Berns A., Thomas G. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 2000 Jul 1;14(13):1617–1630. [PMC free article] [PubMed] [Google Scholar]
- Gutmann D. H., Geist R. T., Xu H. m., Kim J. S., Saporito-Irwin S. Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum Mol Genet. 1998 Mar;7(3):335–345. doi: 10.1093/hmg/7.3.335. [DOI] [PubMed] [Google Scholar]
- Gutmann D. H., Giordano M. J., Fishback A. S., Guha A. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology. 1997 Jul;49(1):267–270. doi: 10.1212/wnl.49.1.267. [DOI] [PubMed] [Google Scholar]
- Gutmann D. H., Haipek C. A., Hoang Lu K. Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations. J Neurosci Res. 1999 Dec 1;58(5):706–716. [PubMed] [Google Scholar]
- Gutmann D. H., Hirbe A. C., Haipek C. A. Functional analysis of neurofibromatosis 2 (NF2) missense mutations. Hum Mol Genet. 2001 Jul 1;10(14):1519–1529. doi: 10.1093/hmg/10.14.1519. [DOI] [PubMed] [Google Scholar]
- Hitotsumatsu T., Iwaki T., Kitamoto T., Mizoguchi M., Suzuki S. O., Hamada Y., Fukui M., Tateishi J. Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol. 1997 Mar;93(3):225–232. doi: 10.1007/s004010050608. [DOI] [PubMed] [Google Scholar]
- Huynh D. P., Mautner V., Baser M. E., Stavrou D., Pulst S. M. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. J Neuropathol Exp Neurol. 1997 Apr;56(4):382–390. doi: 10.1097/00005072-199704000-00007. [DOI] [PubMed] [Google Scholar]
- Kluwe L., Bayer S., Baser M. E., Hazim W., Haase W., Fünsterer C., Mautner V. F. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes. Hum Genet. 1996 Nov;98(5):534–538. doi: 10.1007/s004390050255. [DOI] [PubMed] [Google Scholar]
- Kluwe L., MacCollin M., Tatagiba M., Thomas S., Hazim W., Haase W., Mautner V. F. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene. Am J Med Genet. 1998 May 18;77(3):228–233. [PubMed] [Google Scholar]
- Kluwe L., Mautner V. F. Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet. 1998 Dec;7(13):2051–2055. doi: 10.1093/hmg/7.13.2051. [DOI] [PubMed] [Google Scholar]
- Kluwe L., Mautner V., Heinrich B., Dezube R., Jacoby L. B., Friedrich R. E., MacCollin M. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet. 2003 Feb;40(2):109–114. doi: 10.1136/jmg.40.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krawczak M., Reiss J., Cooper D. N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet. 1992 Sep-Oct;90(1-2):41–54. doi: 10.1007/BF00210743. [DOI] [PubMed] [Google Scholar]
- López-Correa C., Zucman-Rossi J., Brems H., Thomas G., Legius E. NF2 gene deletion in a family with a mild phenotype. J Med Genet. 2000 Jan;37(1):75–77. doi: 10.1136/jmg.37.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mautner V. F., Lindenau M., Baser M. E., Hazim W., Tatagiba M., Haase W., Samii M., Wais R., Pulst S. M. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery. 1996 May;38(5):880–886. doi: 10.1097/00006123-199605000-00004. [DOI] [PubMed] [Google Scholar]
- Moyhuddin A., Baser M. E., Watson C., Purcell S., Ramsden R. T., Heiberg A., Wallace A. J., Evans D. G. R. Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet. 2003 Jun;40(6):459–463. doi: 10.1136/jmg.40.6.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mérel P., Hoang-Xuan K., Sanson M., Bijlsma E., Rouleau G., Laurent-Puig P., Pulst S., Baser M., Lenoir G., Sterkers J. M. Screening for germ-line mutations in the NF2 gene. Genes Chromosomes Cancer. 1995 Feb;12(2):117–127. doi: 10.1002/gcc.2870120206. [DOI] [PubMed] [Google Scholar]
- Nagase H., Miyoshi Y., Horii A., Aoki T., Ogawa M., Utsunomiya J., Baba S., Sasazuki T., Nakamura Y. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res. 1992 Jul 15;52(14):4055–4057. [PubMed] [Google Scholar]
- Olschwang S., Tiret A., Laurent-Puig P., Muleris M., Parc R., Thomas G. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell. 1993 Dec 3;75(5):959–968. doi: 10.1016/0092-8674(93)90539-3. [DOI] [PubMed] [Google Scholar]
- Otsuka Goro, Saito Kiyoshi, Nagatani Tetsuya, Yoshida Jun. Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. J Neurosurg. 2003 Sep;99(3):480–483. doi: 10.3171/jns.2003.99.3.0480. [DOI] [PubMed] [Google Scholar]
- Parry D. M., Eldridge R., Kaiser-Kupfer M. I., Bouzas E. A., Pikus A., Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994 Oct 1;52(4):450–461. doi: 10.1002/ajmg.1320520411. [DOI] [PubMed] [Google Scholar]
- Parry D. M., MacCollin M. M., Kaiser-Kupfer M. I., Pulaski K., Nicholson H. S., Bolesta M., Eldridge R., Gusella J. F. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet. 1996 Sep;59(3):529–539. [PMC free article] [PubMed] [Google Scholar]
- Rouleau G. A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993 Jun 10;363(6429):515–521. doi: 10.1038/363515a0. [DOI] [PubMed] [Google Scholar]
- Ruttledge M. H., Andermann A. A., Phelan C. M., Claudio J. O., Han F. Y., Chretien N., Rangaratnam S., MacCollin M., Short P., Parry D. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet. 1996 Aug;59(2):331–342. [PMC free article] [PubMed] [Google Scholar]
- Sainio M., Jäskeläinen J., Pihlaja H., Carpén O. Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus. Neurology. 2000 Mar 14;54(5):1132–1138. doi: 10.1212/wnl.54.5.1132. [DOI] [PubMed] [Google Scholar]
- Sainio M., Strachan T., Blomstedt G., Salonen O., Setälä K., Palotie A., Palo J., Pyykkö I., Peltonen L., Jäskeläinen J. Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree. Neurology. 1995 Jul;45(7):1314–1322. doi: 10.1212/wnl.45.7.1314. [DOI] [PubMed] [Google Scholar]
- Sainz J., Huynh D. P., Figueroa K., Ragge N. K., Baser M. E., Pulst S. M. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet. 1994 Jun;3(6):885–891. doi: 10.1093/hmg/3.6.885. [DOI] [PubMed] [Google Scholar]
- Scoles D. R., Huynh D. P., Morcos P. A., Coulsell E. R., Robinson N. G., Tamanoi F., Pulst S. M. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat Genet. 1998 Apr;18(4):354–359. doi: 10.1038/ng0498-354. [DOI] [PubMed] [Google Scholar]
- Scoles Daniel R., Chen Mercy, Pulst Stefan-M. Effects of Nf2 missense mutations on schwannomin interactions. Biochem Biophys Res Commun. 2002 Jan 11;290(1):366–374. doi: 10.1006/bbrc.2001.6178. [DOI] [PubMed] [Google Scholar]
- Soravia C., Berk T., Madlensky L., Mitri A., Cheng H., Gallinger S., Cohen Z., Bapat B. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet. 1998 Jun;62(6):1290–1301. doi: 10.1086/301883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spirio L., Olschwang S., Groden J., Robertson M., Samowitz W., Joslyn G., Gelbert L., Thliveris A., Carlson M., Otterud B. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993 Dec 3;75(5):951–957. doi: 10.1016/0092-8674(93)90538-2. [DOI] [PubMed] [Google Scholar]
- Stemmer-Rachamimov A. O., Xu L., Gonzalez-Agosti C., Burwick J. A., Pinney D., Beauchamp R., Jacoby L. B., Gusella J. F., Ramesh V., Louis D. N. Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol. 1997 Dec;151(6):1649–1654. [PMC free article] [PubMed] [Google Scholar]
- Su L. K., Barnes C. J., Yao W., Qi Y., Lynch P. M., Steinbach G. Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis. Am J Hum Genet. 2000 Aug 3;67(3):582–590. doi: 10.1086/303058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
- Wellenreuther R., Kraus J. A., Lenartz D., Menon A. G., Schramm J., Louis D. N., Ramesh V., Gusella J. F., Wiestler O. D., von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol. 1995 Apr;146(4):827–832. [PMC free article] [PubMed] [Google Scholar]
- Zhao Y., Kumar R. A., Baser M. E., Evans D. G. R., Wallace A., Kluwe L., Mautner V. F., Parry D. M., Rouleau G. A., Joe H. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2). Genet Epidemiol. 2002 Oct;23(3):245–259. doi: 10.1002/gepi.10181. [DOI] [PubMed] [Google Scholar]
- Zucman-Rossi J., Legoix P., Der Sarkissian H., Cheret G., Sor F., Bernardi A., Cazes L., Giraud S., Ollagnon E., Lenoir G. NF2 gene in neurofibromatosis type 2 patients. Hum Mol Genet. 1998 Dec;7(13):2095–2101. doi: 10.1093/hmg/7.13.2095. [DOI] [PubMed] [Google Scholar]